Design to Value: Shaping a Better Built Environment | Martin Wood

He notes that traditional architectural education needs to adapt to tech-savvy students who often know more about certain tools than their professors.

Unfortunately, we sometimes find ourselves in the conventional engineering situation of having to limit the number of options that we look at because we haven't got the time or the resources to look at too many.Clearly, it is fine to narrow down a set of options on a rational basis.

But if it's simply that we don't have time, we are at risk of staying away from the optimum solution.That means more cost and more time which, ultimately, is going to affect the patient who is at the end of that supply chain.As a result, these are particularly important factors to consider in the design and construction of pharmaceutical facilities..

In summary, Chips allow us many different perspectives on parts of a project.And crucially, they provide the common language for communication between all the different people involved in executing that project..

Improving pharmaceutical facility design with Chips, generative design and automation.

We are now using chips as the basis of generative designs to allow us to automate the design process.The clue is in the name.

“Design for Manufacture and Assembly” is a design approach.Conventional design either has a presumption towards conventional construction or is agnostic regarding the construction method.

Conversely, a DfMA design is developed to be constructed in a particular way..When designing for manufacture and assembly, the designer must find the best way to meet the client’s requirements by considering the most efficient way to manufacture elements of the building and the most efficient way to assemble them on site.